2Lebvitz HE, Dole JE, Patwardhnan R, et al. Rosiglitazone monotherapy is effective in parle nts with type 2 diabetes. J Cin En-docrinol Metab, 2001, 86: 280-288.
5Mohanty P, Aljada A, Ghanim H, et al. Evidence for a potent anti-inflamatory effect of rosiglitazone. J Clin Endocriol Meatab,2004,89:2728-35.
6Stewatd M, Jones NP, Kridedr M, et al. Combiation effects If rosiglitazone and atovcas tatin on the dyslipidemia association with type 2 diabetes. Diabetologia,2001,44: Abstract 854.
7Freed M, Fuell D, Menci L, et al. Effects of combination therapy with rosiglitaxzone and glibenclamide on PAI-1 and tPA in patients with type 2 diabetes. Doabe Tologia, 2Q00,43 : A1024.
2Sutton SJM, Rendell M, Pandona P, et al. A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic cantrol in patients with type 2 diabetes [ J]. Diabetes Care, 2002, 25 ( 11 ) :2058-64,.
3Purrello F, Rabuazza AM. Metabolic factors that affect beta-cell function and survival[J]. Diabet Nutr Metab,2000;13:84-91.
4Scheen A J, Lefebvere PJ. Oral anti-diabetic agents: a guide to selection[J]. Drugs,1998 ;55(2) :225-36.
5Garber A J, Duncan TG, Goodman AM, et al. Efficacy of metformin in type 2 diabetes : results of a double-blind, placebo-controlled, dose-response trial[ J]. AJMN, 1997 ; 103:491-7.
6TOOKE J E, HANNEMANN M M. Adverse endothelial function and insulin resistance syndrome [ J ]. J Intern Med, 2000,247 (4): 425-431.
7CLELAND S J, PETRIE J R, SAMLL M, et al. Insulin action is associated with endothelial function in hypertens and type 2 diabetes [J]. Hypertension,2000,35[ 1 pt 2] :507-511.
9HAFFNER S M, KENNEDY E, GONZALEZ C, et al. A prospective analysis of HOMA model. The Mexico City diabetes study[ J]. Diabetes Care, 1996, 19(10): 1138-1141.
10CELERMAJER D S,SOREN K E,GOOCH V M,et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [ J ]. Lancet, 1992,340(8828): 1111-1115.
2Haffner SM,Miettinen H,Stern MP.The homeostasis model in the San Autonio heart study.Diabetes Care,1997,20:1087-1092.
3Smiley D,Umpierrez G.Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with type 2 diabetes.Expert Opin Pharmacother,2007,8:1353-1364.
4Rosenstock J,Rood J,Cobitz A,et al.Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazoneor metformin in patients with uncontrolled type 2 diabetes.Diabetes Obes Metab,2006,8:650-660.
5Hamann A,Garcia-Puig J,Paul G,et al.Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with type 2 diabetes inadequately controlled on metformin alone.Exp Clin Endocrinol Diabetes,2008,116:6-13.
6Schuyler M, Niewoehner D, Inkley S, et al. Abnormal lung elasticity in ju- venile diabetes mellitus. Am Rev Resp Dis, 1976,113 : 37-41.
8Robert AB, Flanders KC, Heine UI, et al. Transforming Growth factor- : multifunctional regulator of differentiation and development. Philos Trans R Soc Lond B Biol Sci, 1990,327 : 145-154.
